March 24th, 2026
Study suggests healing skin without scarring may be possible
New findings by Harvard stem cell biologists suggest it may be possible in the future to regrow wounded skin without scarring.
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Blavatnik Biomedical Accelerator
March 9th, 2026
Unlocking hidden pocket on a billion‑dollar drug target
A research team led by Christina Woo, professor of chemistry and chemical biology, in collaboration with a team of scientists at pharmaceutical company GSK and Scripps Research Institute, discovered a hidden binding pocket on the protein cereblon. The discovery of the allosteric cereblon binder could uncover a new area of cereblon biology to explore for cancer drugs.
March 2nd, 2026
'I think I know how to fix this'
Researchers in Andrew Kruse’s lab overcame a key obstacle in using the hormone relaxin as a therapy for heart disease. With support from Harvard’s Blavatnik Biomedical Accelerator, this discovery led to the launch of Tectonic Therapeutic, which is now testing its relaxin-based drug in clinical trials.
September 25th, 2025
Speeding Discoveries from Lab to Patients
10 new technologies tackling urgent challenges from autoimmune disease to cancer win funding from Blavatnik Biomedical Accelerator.
June 16th, 2025
Chan School for Public Health lab receives funding to tackle obesity and age-related diseases
A lab at Harvard T.H. Chan School of Public Health received industry-sponsored research and aims to translate discoveries about a protein that helps regulate metabolism and inflammation into novel therapeutics for obesity, heart disease, and age-related illnesses.
